DIEBOLD NIXDORF, Inc
DBD· NYSE
Filed Mar 16, 2023 · 10-K · 75 days after period end · 0000028823-23-000078
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $968.80M | $1.06B | $1.11B | $1.15B |
| Net Income | -$149.30M | -$38.30M | -$51.20M | -$122.60M |
| EPS Diluted | — | — | -$0.66 | -$1.60 |
DIEBOLD NIXDORF, Inc · CIK 28823 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 16, 2023 · 75 d after period end